14-day Premium Trial Subscription Try For FreeTry Free

Range Low Price High Price Comment
30 days $12.93 $17.99 Friday, 3rd May 2024 TGTX stock ended at $16.19. This is 1.40% less than the trading day before Thursday, 2nd May 2024. During the day the stock fluctuated 6.52% from a day low at $15.96 to a day high of $17.00.
90 days $12.84 $19.02
52 weeks $6.47 $35.29

Historical TG Therapeutics prices

Date Open High Low Close Volume
May 03, 2024 $16.75 $17.00 $15.96 $16.19 4 771 040
May 02, 2024 $16.20 $16.76 $15.56 $16.42 8 439 860
May 01, 2024 $17.15 $17.99 $14.87 $15.88 18 535 439
Apr 30, 2024 $13.30 $13.75 $12.93 $13.66 5 107 540
Apr 29, 2024 $13.66 $13.85 $13.22 $13.32 2 878 907
Apr 26, 2024 $13.94 $14.01 $13.41 $13.47 2 804 907
Apr 25, 2024 $13.56 $13.99 $13.29 $13.91 3 255 356
Apr 24, 2024 $14.28 $14.35 $13.74 $13.98 2 700 761
Apr 23, 2024 $14.17 $14.57 $14.17 $14.25 3 213 857
Apr 22, 2024 $13.98 $14.31 $13.66 $14.10 2 236 421
Apr 19, 2024 $13.87 $14.01 $13.26 $13.78 3 632 316
Apr 18, 2024 $13.99 $14.63 $13.85 $13.99 3 483 254
Apr 17, 2024 $14.06 $14.13 $13.55 $13.82 3 017 797
Apr 16, 2024 $13.98 $14.17 $13.76 $14.00 1 586 705
Apr 15, 2024 $14.15 $14.58 $13.95 $14.07 2 214 182
Apr 12, 2024 $14.76 $14.87 $13.91 $14.16 3 879 955
Apr 11, 2024 $14.81 $14.98 $14.59 $14.76 1 979 389
Apr 10, 2024 $14.56 $15.07 $14.45 $14.71 2 985 148
Apr 09, 2024 $15.16 $15.37 $14.98 $15.10 1 934 911
Apr 08, 2024 $14.62 $15.03 $14.31 $14.97 1 995 733
Apr 05, 2024 $14.36 $14.65 $14.19 $14.52 2 277 905
Apr 04, 2024 $14.65 $14.88 $14.38 $14.46 2 596 676
Apr 03, 2024 $14.39 $14.59 $14.04 $14.47 2 231 780
Apr 02, 2024 $14.43 $14.59 $14.13 $14.44 2 580 265
Apr 01, 2024 $15.13 $15.18 $14.65 $14.77 2 192 400
Click to get the best stock tips daily for free!

About TG Therapeutics

TG Therapeutics TG Therapeutics, Inc., a commercial stage biopharmaceutical company, focuses on the acquisition, development, and commercialization of novel treatments for B-cell malignancies and autoimmune diseases. Its therapeutic product candidates include Ublituximab, an investigational glycoengineered monoclonal antibody for the treatment of B-cell non-hodgkin lymphoma, chronic lymphocytic leukemia (CLL), and relapsing forms of multiple sclerosis; and Umbra... TGTX Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT